By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

Ozempic

What is new weight loss jab Mounjaro and is it available on the NHS? Manchester Evening News11:53Mounjaro Tirzepatide Global Health

NHS Mounjaro warning as most will not be able to access new weightloss drug Daily Record07:43Mounjaro Tirzepatide Global Health

Zepbound users talk about weight loss as drug maker releases preliminary research ABC News19:17Eli Lilly Mounjaro Novo Nordisk

Eli Lilly's Zepbound tops Novo Nordisk's Wegovy in weight-loss trial Investopedia18:41Eli Lilly Mounjaro Novo Nordisk

CU Anschutz Medical Campus studying if pill form of Ozempic can curb alcohol use 7News Denver23:56Colorado Global Health Health

The growing list of conditions weight-loss drugs could help with The Week (US)13:56Colorado Global Health Health

Khloé Kardashian responds to Ozempic use: ‘Who am I to judge?’ Hindustan Times04:09Khloe Kardashian Kardashians

Khloe Kardashian 'mad' Ozempic didn't exist a decade ago film-news.co.uk01:12Khloe Kardashian Kardashians

Ice Spice answers weight loss rumors and claps at haters All Hip-Hop20:44Ice Spice Hip-Hop Music

Ice Spice claps back against critics amid weight loss and Ozempic rumors with a SpongeBob… MailOnline17:09Ice Spice Hip-Hop Music

How Alison Hammond's childhood trauma and an incident with her drug smuggler father led to a… MailOnline04:28Alison Hammond Drug Trafficking

This Morning star Alison Hammond makes admission about weight loss injections and says 'I'll… Birmingham Live03:40Alison Hammond Drug Trafficking

Eli Lilly to invest $3B in Wisconsin plant to meet obesity drug demand Zacks10:03Eli Lilly Mounjaro Wisconsin

Lilly invests another $3bn in its manufacturing network pharmaphorum09:37Eli Lilly Mounjaro Wisconsin

I'm a pharmacist... here are four things you need to know before having a weight-loss jab MailOnline04:06

Urgent warning over fake online pharmacies selling 'Ozempic' laced with deadly chemicals… MailOnline04:45

Lilly’s Zepbound wins the weight loss duel with Novo’s Wegovy Clinical Trials Arena12:41Novo Nordisk Obesity Pharma

Four oral GLP-1R products in Phase III trials as race intensifies Clinical Trials Arena04:30Novo Nordisk Obesity Pharma

Wegovy and Zepbound are leading this year's weight loss drug prescription surge Quartz11:13Wegovy Mounjaro

Eli Lilly says Zepbound is 'superior' to rival weight loss drug Wegovy Quartz09:07Wegovy Mounjaro

Latest News

In the last 5 minutes

Doctor says five Christmas foods 'suppress appetite and boost weight loss' Daily Record06:19

Popular US-based weight loss drug maker Eli Lilly plans to launch medicine in India next year The Economic Times06:17

In the last 10 minutes

Are Weight-Loss Drugs Impacting the Obesity Rate? Undark06:11

In the last 2 hours

Novo’s $16.5bn Catalent deal cleared by EU Commission pharmaphorum05:15

Eli Lilly Stock Just Got Even Sweeter. Here's Why It's Worth Buying Now The Motley Fool05:00

How Rfk Jr. Could Reverse Our Nation’s Foolish Approach To Obesity Forbes04:32

In the last 4 hours

Eli Lilly to launch its obesity drug at competitive price in India in 2025 The Business Standard02:56

In the last 6 hours

Sale of unapproved US weight loss trial drug exposed in Ireland RTE02:19

In the last 8 hours

Eli Lilly to launch diabetes, obesity drug in India next year The Times of India22:55 8-Dec-24

Yesterday

Prices on weight loss drugs are dropping — What patients need to know Study Finds13:21 8-Dec-24

Mounjaro,‘King Kong’ of weight loss jabs, will be available in Ireland early next year Sunday World11:54 8-Dec-24

Jon Stewart calls out Democrats' 'gag reflex' when they agree with Rfk Jr. or Elon Musk on… Fox News10:30 8-Dec-24

Strictly Come Dancing's Arlene Phillips explains her 'one dieting rule' The Mirror10:03 8-Dec-24

Who gets obesity drugs covered by insurance? In North Carolina, it helps if you’re on Medicaid The Charlotte Observer09:54 8-Dec-24

GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots Medpage Today09:24 8-Dec-24

'Like paracetamol': Inside our weight loss drug black market RTE05:47 8-Dec-24

Ozempic knock-offs are rife with scams Business Insider04:28 8-Dec-24

Revealed: How social media influencers earn thousands from selling prescription Mounjaro jabs… MailOnline03:11 8-Dec-24

In the last 7 days

Fat Joe Calls Ozempic "The Greatest Invention Ever" Hot New Hip Hop21:44 7-Dec-24

Ice Spice Answers Weight Loss Rumors And Claps At Haters All Hip-Hop20:44 7-Dec-24

Ice Spice claps back against critics amid weight loss and Ozempic rumors with a SpongeBob… MailOnline17:09 7-Dec-24

Ice Spice Had A Hilarious Clapback For Body Shamers Upset By Her Recent Weight Loss Uproxx13:46 7-Dec-24

Ah, my beauty past compare (with the present) The Economic Times12:39 7-Dec-24

BioAge shares tumble after decision to halt obesity drug study BioPharma Dive11:37 7-Dec-24

Ice Spice Has A Hilarious Response To Trolls Hating On Her Weight Loss Hot New Hip Hop11:35 7-Dec-24

Ice Spice Claps Back to Haters Over Weight Loss With Help From SpongeBob TMZ.com10:56 7-Dec-24

More and More People Are Microdosing Ozempic Futurism09:29 7-Dec-24

The Ultimate Status Symbol For The Super Rich? A Clean Bill Of Health Vogue09:07 7-Dec-24

Ozempic and booze, a CEO shooting, and Trump tariffs: Business news roundup Quartz09:02 7-Dec-24

Will thinness still be desired when it's 'easy' to achieve? Social media questions whether… MailOnline08:29 7-Dec-24

Could Ozempic treat addiction? The Washington Post07:45 7-Dec-24

3 No-Brainer Growth Stocks to Buy in December The Motley Fool06:53 7-Dec-24

Ozempic curbs drinking, Hawk Tuah's memecoin, Bezos bets on Nvidia rival: The week's most popular stories Quartz05:09 7-Dec-24

How Alison Hammond's childhood trauma and an incident with her drug smuggler father led to a… MailOnline04:28 7-Dec-24

I'm a pharmacist... here are four things you need to know before having a weight-loss jab MailOnline04:06 7-Dec-24

Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's… The Motley Fool03:20 7-Dec-24

How does weight loss drug Mounjaro work and why is it in such high demand? Yahoo! UK & Ireland03:11 7-Dec-24

Ozempic, food noise and the struggle with obesity: Life-changing stories and the stigma of weight loss drugs - Radio… The Irish News01:06 7-Dec-24

What's wrong with female flesh that's no longer firm and smooth? Radio New Zealand22:41 6-Dec-24

Mounjaro, the ‘King Kong’ of weight loss jabs, will be available in Ireland early next year The Irish Independent21:38 6-Dec-24

Zepbound users talk about weight loss as drug maker releases preliminary research ABC News19:17 6-Dec-24

Man arrested on attempted fist-degree murder charges for Oct. shooting in Denver 7News Denver18:56 6-Dec-24

New weight loss pharmacy opens in Marquette Township Upper Michigan Source16:50 6-Dec-24

New study finds obesity costs US industry $347bn a year Pharmaceutical Technology16:42 6-Dec-24

Chinese and Indian drugmakers prepare to cash in on Ozempic craze Nikkei Asian Review16:04 6-Dec-24

5 things: Food recalls aren’t on the rise—but social media is Supermarket News15:11 6-Dec-24

Doctors weigh societal costs of using drugs to treat obesity crisis ABC Online14:35 6-Dec-24

Last-minute Biden proposal stokes division with GOP The Raw Story14:11 6-Dec-24

Nature study finds obesity costs US industry $347bn a year Pharmaceutical Technology13:39 6-Dec-24

Novo Wins EU Approval for Deal to Acquire Catalent Plants BNN Bloomberg13:34 6-Dec-24

Better Alternatives to Words of Affirmation The Good Men Project13:32 6-Dec-24

Novo Holdings' $16.5 billion Catalent buy wins EU antitrust approval Yahoo! UK & Ireland13:10 6-Dec-24

Should Pharmaceutical Companies Sell Weight-Loss Drugs Directly to Consumers? Medpage Today12:37 6-Dec-24

Lilly adds to obesity drug production push with $3B investment BioPharma Dive12:21 6-Dec-24

6 Standouts at Art Basel Miami Beach: From Claude Cahun’s Surrealist Photos to a Tour-De-Force Ernie Barnes artnet12:04 6-Dec-24

Joe Rogan, Derek MPMD Talk Tren Use Making People ‘Ultra-Violent’ and President Biden Spearheading Anti-Steroid Campaign FitnessVolt11:30 6-Dec-24

Joshua Oppenheimer’s ‘The End’ Is the Only 2024 Movie Musical That Matters — In Review IndieWire11:21 6-Dec-24

Khloe Kardashian & Kris Jenner Enjoy Night Out in London Just Jared (Weblog)11:13 6-Dec-24

Novo Nordisk Urges FDA to Ban Compounded Semaglutide – What Weight-Loss Clinic Owners Need to Know JD Supra10:49 6-Dec-24

Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand Zacks10:03 6-Dec-24

AbbVie’s Skyrizi retains DTC spending crown, as Novo’s Wegovy sees first entry FiercePharma09:58 6-Dec-24

Lilly invests another $3bn in its manufacturing network pharmaphorum09:37 6-Dec-24

The contrarian addiction Angry Bear (Weblog)09:33 6-Dec-24

How the weight loss drug tirzepatide is also helping heart failure patients Science News Online09:15 6-Dec-24

Weight loss drug Mounjaro will be available via the NHS for some people living with obesity Women's Health UK09:12 6-Dec-24

This recent study shows where some of the big fish are taking some of their money ForexLive.com08:38 6-Dec-24

Hiring bounced back in November, adding 227,000 jobs Quartz08:37 6-Dec-24

Trump taps Elon Musk's ally and venture capitalist David Sacks as AI and crypto czar Quartz08:24 6-Dec-24

Can You Go On Ozempic If You Want To Get Pregnant? Women's Health08:23 6-Dec-24

Pharma Stock Roundup: LLY's Zepbound Success, FDA Updates for MRK, JNJ Zacks07:30 6-Dec-24

How to Play LLY Stock as Zepbound Beats NVO's Wegovy in Obesity Study Zacks07:30 6-Dec-24

This Week in Health News: 13 Stories You Need to See PR Newswire (Press Release)06:15 6-Dec-24

Government coverage of Ozempic splits Republicans Semafor06:14 6-Dec-24

Elsa Hosk turns heads in a strapless satin minidress as she joins a glamorous Brooks Nader at… MailOnline06:04 6-Dec-24

Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street The Motley Fool05:48 6-Dec-24

Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup Quartz05:03 6-Dec-24

Urgent warning over fake online pharmacies selling 'Ozempic' laced with deadly chemicals… MailOnline04:45 6-Dec-24

Polycystic ovary syndrome: What it is, how it's treated and why it's often misunderstood The Week (US)02:07 6-Dec-24

FDA chief defends work on obesity, food to US Senate as agency awaits fierce critic Rfk Jnr Times LIVE01:08 6-Dec-24

CU Anschutz Medical Campus studying if pill form of Ozempic can curb alcohol use 7News Denver23:56 5-Dec-24

Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial Investopedia18:41 5-Dec-24

Weight loss may bring big healthcare savings to Americans UPI16:35 5-Dec-24

Shaquille O'Neal Roasts Charles Barkley's Weight In Interview With Boxing Legend Sports Illustrated16:18 5-Dec-24

Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars Yahoo! UK & Ireland15:46 5-Dec-24

'This quasi-coup attempt has baffled most experts' The Week (US)14:12 5-Dec-24

The growing list of conditions weight-loss drugs could help with The Week (US)13:56 5-Dec-24

Kathy Bates Is Unrecognizable After Stunning Weight Loss Transformation The List13:31 5-Dec-24

Fans Call Out Donatella Versace For Looking ‘Normal’ And Not Botched In New Photos DoYouRemember?13:06 5-Dec-24

What is new weight loss jab Mounjaro and is it available on the NHS? Manchester Evening News11:53 5-Dec-24

Why some people don’t lose weight with Wegovy Anglia Ruskin University11:43 5-Dec-24

Untangling GLP-1 Risks: Are Side Effects Overblown? Medpage Today11:20 5-Dec-24

Wegovy and Zepbound are leading this year's weight loss drug prescription surge Quartz11:13 5-Dec-24

Tirzepatide: Obesity injection will get phased rollout to avoid overwhelming GPs British Medical Journal11:07 5-Dec-24

Weight Loss Brings Americans Big Health Care Savings HealthDay11:02 5-Dec-24

Tirzepatide Outperforms Semaglutide in Weight Loss Trial American Journal of Managed Care10:49 5-Dec-24

3 US Penny Stocks With Market Caps Under $200M To Consider Simply Wall St10:10 5-Dec-24

Proposal for Medicaid, Medicare Coverage of Obesity Drugs Could Prove Difficult American Journal of Managed Care09:38 5-Dec-24

GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills… Business Wire (Press Release)09:02 5-Dec-24

Watchdog clamps down on illegal ‘skinny jab’ ads targeting ‘vulnerable people’ ITV08:59 5-Dec-24

Alabama task force grapples with high costs of weight-loss drugs amid rising obesity rates Alabama Daily News08:54 5-Dec-24

Alison Hammond finally reveals exactly how she lost 11 stone and gets frank about Ozempic The Mirror08:13 5-Dec-24

NHS Mounjaro warning as most will not be able to access new weightloss drug Daily Record07:43 5-Dec-24

Weight loss drug Wegovy may soon be reimbursed in France The Connexion07:34 5-Dec-24

Denmark raises 2025 GDP outlook, benefits from Novo Nordisk's growth Yahoo! UK & Ireland07:28 5-Dec-24

Mounjaro: What you need to know about ‘King Kong of weight-loss drugs’ The Independent07:06 5-Dec-24

What is Mounjaro and how does it work? Evening Standard06:46 5-Dec-24

How Ozempic will change the skin care industry in 2025 cosmeticsbusiness.com06:43 5-Dec-24

How new NHS weight loss jab Mounjaro works and eligibility amid 12-year waiting list The Mirror06:27 5-Dec-24

What is Mounjaro – the new NHS weight loss jab? Metro.co.uk06:26 5-Dec-24

LLY's Zepbound Outshines NVO's Wegovy in Head-to-Head Obesity Study Zacks06:03 5-Dec-24

Eli Lilly: Breakthrough Trial Results Set Stage for Market Growth, Stock Gains Investing.com UK05:51 5-Dec-24

The scientists giving Ozempic to pensioners to stave off dementia i News05:14 5-Dec-24

Doctor warns of deadly unforeseen side effects of Mounjaro as NHS is given 12 years to roll out … MailOnline05:11 5-Dec-24

Chappell Roan, semaglutide and Kamala Harris: the most mispronounced words of 2024 Yahoo! UK & Ireland05:09 5-Dec-24

Hedge funds turn to doctors and scientists to gain pharma market edge HedgeWeek04:32 5-Dec-24

view more headlines

9 Dec 06:19

About our Ozempic news

Latest news on Ozempic, Wegovy, Rybelsus: semaglutide weight loss drugs making headlines for remarkable results, high demand, and celebrity use. Stay updated on these popular GLP-1 medications.

Ozempic, Wegovy, and Rybelsus are brand names for semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes treatment. These injectable and oral medications have gained significant attention for their impressive weight loss effects, with many users reporting rapid and substantial body weight reductions. As a result, demand for semaglutide drugs has skyrocketed, leading to shortages and waiting lists in some areas.

Our semaglutide news feed brings you the latest updates on these groundbreaking weight loss drugs from reliable medical sources, pharmaceutical companies like Novo Nordisk, and real-world patient experiences. Stay informed about the efficacy, safety, and potential side effects of Ozempic, Wegovy, and Rybelsus, as well as ongoing clinical trials and research into their long-term effects and potential new applications.

In addition to their medical aspects, semaglutide drugs have become a cultural phenomenon, with celebrities and influencers openly discussing their use of Ozempic and Wegovy for weight loss. Our feed covers these high-profile endorsements and the ensuing public discourse about the ethics and accessibility of these treatments. We also explore the societal implications of the growing popularity of semaglutide, including its impact on body image standards and the potential for exacerbating existing inequalities in healthcare access.

As the demand for Ozempic, Wegovy, and Rybelsus continues to grow, our feed keeps you updated on supply chain issues, regulatory developments, and efforts by manufacturers to ramp up production and expand availability. We also cover debates surrounding insurance coverage for these weight loss drugs and the evolving policies of healthcare providers and payers.

With obesity rates on the rise globally, the advent of effective weight loss medications like semaglutide has significant implications for public health and healthcare systems. Our semaglutide news feed delves into these broader contexts, exploring the potential of these drugs to combat the obesity epidemic and their role in comprehensive weight management strategies alongside lifestyle changes and other interventions.

Stay at the forefront of the rapidly evolving landscape of semaglutide weight loss treatments with our continuously updated Ozempic, Wegovy, and Rybelsus news feed. Whether you're a healthcare professional, a person struggling with obesity, or simply interested in this groundbreaking development, our feed is your go-to source for comprehensive, nuanced coverage of these remarkable drugs.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.